Urologic Design Closes $1.2M Pre-Seed for Incontinence Device
Image
BRANFORD, CT – October 29, 2026 -- Urologic Design closed an oversubscribed $1.2 million pre-seed round to move its patented urinary incontinence device toward a first-in-human study.
Angel Investor Forum leads a syndicate of regional and university-linked backers
Angel Investor Forum, described as Connecticut's primary angel group, led the equity round. HBS Alumni Angels of Boston, Haven Founders Fund, Connecticut Innovations and Yale Angels joined, along with several individual investors.
Matthew Stannard, Life Sciences Lead at Angel Investor Forum, said the firm backed the company because it bridges the gap between absorbent products and surgery. He called first-in-human testing "an important step on the path to commercialization."